Exact Sciences to Participate in September Investor Conferences

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

• Wells Fargo Healthcare Conference, Boston
  Fireside chat on Wednesday, September 3, 2025 at 1:30 p.m. ET
• Baird Global Healthcare Conference, New York
  Fireside chat on Tuesday, September 9, 2025 at 10:50 a.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences helps patients and health care providers make timely, informed decisions before, during, and after a cancer diagnosis. The company’s growing portfolio includes well-established brands such as Cologuard® and Oncotype DX®, along with innovative solutions like Oncodetect™ for molecular residual disease and recurrence monitoring. Exact Sciences continues to invest in a robust pipeline of advanced cancer diagnostics aimed at improving outcomes. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250819553548/en/

Derek Leckow
Exact Sciences Corp.
[email protected]
608-893-0009

Source: Exact Sciences Corp.

You May Also Be Interested In

• STRATUM Launches Strategic Asset Intelligence Platform for African Mining and EV Battery Minerals
• DREYER'S GRAND ICE CREAM, INC. ISSUES VOLUNTARY RECALL ON SELECT OUTSHINE FRUIT BARS DUE TO POSSIBLE FOREIGN MATTER CONTAMINATION
• Crypto News Today: MemeToro Presale Gains Attention as JPMorgan Boosts IBIT and ETHA Holdings by Double Digits